Medical Biology Division 2012

Chang, Tse Wen

  • Chang TW*, Chen JB, Chu, CY , 2012, “The pharmacological mechanisms of omalizumab in patients with very high IgE levels—Clues from studies on atopic dermatitis”, Dermatologica Sinica, 30(4), 147-153. (SCIE) (IF: 0.921; SCIE ranking: 91.2%)
  • Shiung, Y.Y., Chiang, C.Y., Chen, J.B., Wu, P.C., Hung, A.F., Lu, D.C.S., Pan, R.L., and Chang, T.W. , 2012, “An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors”, Immunobiology, 217(7), 676-683. (SCIE) (IF: 2.788; SCIE ranking: 64.8%)
  • Lin CJ, Chen NY, Chen JB, Lu CS, Hung AF, Shiung YY, Wu PC, Pan RL, Chang TW, 2012, “CvarepsilonmX peptide-carrying HBcAg virus-like particles induced antibodies that down-regulate mIgE-B lymphocytes.”, Molecular immunology, 52(3-4), 190-199. (SCIE) (IF: 3.641; SCIE ranking: 39.7%,45.3%)

Chen, Chien-Jen

  • Shen J, Wang S, Zhang YJ, Kappil M, Wu HC, Kibrya MG, Wang Q, Jasmine F, Ahsan H, Lee PH, Yu MW, Chen CJ, Santella RM, 2012, “Genome-wide DNA methylation profiles In hepatocellular carcinoma”, Hepatology, 55(6), 1799-1808. (SCIE) (IF: 14.679; SCIE ranking: 6.8%)
  • Liao YT, Chen CJ, Li WF, Hsu LI, Tsai LY, Huang YL, Sun CW, Chen WJ*, Wang SL*, 2012, “Elevated lactate dehydrogenase activity and cardiovascular mortality in the arsenic-endemic areas of southwestern Taiwan”, Toxicol Appl Pharmacol, 262, 232-237. (SCIE) (IF: 3.347; SCIE ranking: 33.6%,30.4%)
  • Wu HC, Wang Q, Yang HI, Tsai WY, Chen CJ, Santella RM*, 2012, “Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study”, Carcinogenesis, 33(7), 1340-1345. (SCIE) (IF: 4.603; SCIE ranking: 31.6%)
  • ang HI*, Hung HL, Lee MH, Liu J, Jen CL, Su J, Wang LY, Lu SN, You SL, Iloeje UH, Chen CJ for the REVEAL-HBV Study Group, 2012, “Incidence and determinants of spontaneous seroclearance of HB e antigen and DNA in patients with chronic hepatitis B”, Clinical Gastroenterology and Hepatology, 10(5), 527-534. (SCIE) (IF: 8.549; SCIE ranking: 11.4%)
  • Iloeje UH, Yang HI, Chen CJ, 2012, “Natural history of chronic hepatitis B: what exactly has REVEAL Revealed?”, Liver Int, 32, 1333-1341. (SCIE) (IF: 5.175; SCIE ranking: 21.6%)
  • Chang C, Middeldorp J, Yu KJ, Juwana H, Hsu WL, Lou PJ, Wang CP, Chen JY, Liu MY, Pfeiffer RM, Chen CJ, Hildesheim A, 2012, “Characterization of ELISA detection of broad-spectrum anti- Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma”, Journal of Medical Virology, 85(3), 524-529. (SCIE) (IF: 2.021; SCIE ranking: 75.7%)
  • Chuang LC, Hu CY, Chen HC, Lin PJ, Lee B, Lin CY, Pan MH, Chou YC, You SL, Hsieh CY, Chen CJ*, 2012, “Associations of Human Leukocyte Antigen Class II Genotypes with Human Papillomavirus 18 Infection and Cervical Intraepithelial Neoplasia Risk”, CANCER, 118, 223-231. (SCIE) (IF: 5.772; SCIE ranking: 18.9%)
  • Huang CY, Chen CA, Chen YL, Chiang CJ, Hsu TH, Lin MC, Lai MS, Chen CJ, You SL, Cheng WF*, 2012, “ Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort- 30-year population-based registry in Taiwan”, PLoS One, 7(12), e51372. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Lien WC, Lee WC, Wang HP, Chen YC, Liu KL, Chen CJ, 2012, “Appendicolith delays resolution of appendicitis following nonoperataive management ”, J Gastrointest Surg, 16(12), 2274-2279. (SCIE) (IF: 2.573; SCIE ranking: 69.3%,31%)
  • Chen JW, Wang SL, Wang YH, Sun CW, Huang YL, Chen CJ, Li WF, 2012, “Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in arseniasis endemic area of southwestern Taiwan”, Chemosphere, 88(4), 432-438. (SCIE) (IF: 5.778; SCIE ranking: 10.9%)
  • Liao SF, Lee WC, Chen HC, Chuang LC, Pan MH, Chen CJ, 2012, “Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more then ten years”, Cancer Cause Control, 23, 703-708. (SCIE) (IF: 2.375; SCIE ranking: 72.1%,40.4%)
  • Boffetta P, Hazelton WD, Chen Y, Sinha R, Inoue M, Gao YT, Koh WP, Shu XO, Grant EJ, Tsuji I, Nishino Y, You SL, Yoo KY, Yuan JM, Kim J, Tsugane S, Yang G, Wang R, Xiang YB, Ozasa K, Nagai M, Kakizaki M, Chen CJ, Park SK, Shin A, Ahsan H, Qu CX, Lee JE, Thornquist M, Rolland B, Feng Z, Zheng W, Potter JD, 2012, “Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine: a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium”, Ann Oncol, 23(7), 1894-1898. (SCIE) (IF: 18.274; SCIE ranking: 3.7%)
  • Lee MH, Yang HI, Jen CL, You SL, Wang LY, Chen WJ, Chen CJ*, 2012, “Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study”, J Infect Dis, 206(4), 469-477. (SCIE) (IF: 5.022; SCIE ranking: 25.2%,12%,19.1%)
  • Chang CM, Yu KJ, Hsu WL, Major JM, Chen JY, Lou PJ, Liu MY, Diehl SR, Goldstein AM, Chen CJ, Hildesheim A*, 2012, “Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families”, Brit J Cancer, 106, 206–209. (SCIE) (IF: 5.791; SCIE ranking: 18.4%)
  • Demarteau N, Chen HC, Tang CH, Chen CJ, Van Kriekinge G, 2012, “Cost-effectiveness analysis of the bivalent compared with the quadrivalent human papillomavirus vaccines in Taiwan”, Value in Health, 15(5), 622-631. (SCIE, SSCI) (IF: 4.748; SCIE ranking: 6.9%; SSCI ranking: 5.7%,5.1%)
  • Tseng CH, Chen CJ, Landolph JR Jr, 2012, “Diabete and cancer: epidemiological, clinical and experimental perspectives (editorial)”, Experimental Diabetes Research, 2012, 101802.
  • Hsu WL, Tse KP, Liang S, Chien YC, Su WH, Yu KJ, Cheng YJ, Tsang NM, Hsu MM, Chang KP, Chen IH, Chen TI, Yang CS, Golstein AM, Chen CJ, Chang YS*, Hildesheim A, 2012, “Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma”, PLoS One, 7(8), e42767. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Liao SF, Yang HI, Lee MH, Chen CJ, Lee WC*, 2012, “Fifteen-year population attributable fractions and causal pies of risk factprs for newly developed hepatocellular carcinoma in 11,801 male residents in Taiwan”, PLoS One, 7, e34779. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Hosgood HD III, Wang WC, Hong YC, Wang JC, Chen K, Chang IS, Chen CJ, Lu D, Yin Z, Wu C, Zheng W, Qian B, Park JY, Kim YH, Chatterjee N, Chen Y, Chang GC, Hsiao CF, Yeager M, Tsai YH, Wei H, Kim YT, Wu W, Zhao Z, Chow WH, Zhu X, Lo YL, Sung SW, Chen KY, Yuenger J, Kim JH, Huang L, Chen YH, Gao Y, Kim JH, Huang MS, Jung TH, Caporaso N, Zhao X, Huan Z, Yu D, Kim CH, Su WC, Shu X, Kim IS, Bassig B, Chen YM, Cha SI, Tan W, Chen H, Yang TY, Sung JS, Wang CL, Li X, Park KH, Yu CJ, Ryu JS, Xiang Y, Hutchinson A, Kim JS, Cai Q, Landi MT, Lee KM, Hung JY, Park JY, Tucker M, Lin CC, Ren Y, Perng RP, Chen CY, Li J, Chen KC, Li YJ, Chiu YF, Tsai FY, Yang PC, Fraumeni JF Jr, Seow A, Lin D, Zhou B, Chanock S, Hsiung CA, Rothman N, Lan Q, 2012, “Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia”, Human Genetics, 131(7), 1197-1203. (SCIE) (IF: 5.743; SCIE ranking: 11.8%)
  • Shen J, Wang S, Zhang YJ, Kappil MA, Wu HC, Kibriya MG, Wang Q, Jasmine F, Ahsan H, Lee PH, Yu MW, Chen CJ, Santella RM*, 2012, “Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma”, Epigenetics, 7(11), 1230-1237. (SCIE) (IF: 4.251; SCIE ranking: 23%,29%)
  • Lan Q, Hsiung CA, Matsuo K, Hong YC, Seow A, Wang Z, Hosgood HD 3rd, Chen K, Wang JC, Chatterjee N, Hu W, Wong MP, Zheng W, Caporaso N, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Yuenger J, Jacobs KB, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, Wu C, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein R, Chung CC, Oh IJ, Chen KY, Berndt SI, He X, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Shu XO, Chen YM, Liu L, Kang CH, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Sihoe AD, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni JF Jr, Lin D, Chanock SJ, Rothman N, 2012, “Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia”, Nature Genetics, 44(12), 1330-1335. (SCIE) (IF: 27.605; SCIE ranking: 1.1%)
  • Chuang LC, Chen HC, Chen CJ*, 2012, “Human papillomavirus infection and gastrointestinal cancers: a review”, Eur J Clin Med Oncol-EJCMO, 4, 47-53.
  • Lee MH, Yang HI, Chen CJ, for the REVEAL-HCV Study Group, 2012, “Long-term health outcomes of chronic hepatitis C patients: a review of findings from R.E.V.E.A.L.-HCV cohort study”, BIOMEDICINE, 2(3), 99-107.
  • Hsu WL, Pan WH, Chien YC, Yu KJ, Cheng YJ, Chen JY, Liu MY, Hsu MM, Lou PJ, Chen IH, Yang CS, Hildesheim A, Chen CJ, 2012, “Lowered risk of nasopharyngeal carcinoma and intake of plant vitamin, fresh fish, green tea and coffee: a Case-Control study in Taiwan”, PLoS One, 7(7), e41779. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Lien WC, Chen CJ, 2012, “Male gender is a risk factor for recurrent appendicitis following nonoperative treatment: reply”, World J Surg, 36, 488-489. (SCIE) (IF: 2.234; SCIE ranking: 38.1%)
  • Hwang LC, Bai CH, Sun CA, Chen CJ, 2012, “Prevalence of metabolically healthy obesity and its impacts onincidences of hypertension,diabetes and the metabolic syndrome in Taiwan”, Asia Pac J Clin Nutr, 21, 227-233. (SCIE) (IF: 1.236; SCIE ranking: 82%)

Hsiao, Michael

  • Yeh CT, Wu AT, Chang PM, Chen KY, Yang CN, Yang SC, Ho CC, Chen CC, Kuo YL, Lee PY, Liu YW, Yen CC, Hsiao M, Lu PJ, Lai JM, Wang LS, Wu CH, Chiou JF, Yang PC, Huang CY, 2012, “Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer”, American Journal of Respiratory and Critical Care Medicine, 186(11), 1180-1188. Cite 30. (SCIE) (IF: 17.452; SCIE ranking: 8.3%,3.1%)
  • Cheng PW, Wu AT, Lu PJ, Yang YC, Ho WY, Lin HC, Hsiao M, Tseng CJ, 2012, “Central hypotensive effects of neuropeptide Y are modulated by endothelial nitric oxide synthase after activation by ribosomal protein S6 kinase”, Brit J Pharmacol, 167(5), 1148-1160. Cite 2. (SCIE) (IF: 7.73; SCIE ranking: 3.3%)
  • Wang CH, Ma N, Lin YT, Wu CC, Hsiao M, Lu FL, Yu CC, Chen SY, Lu J, 2012, “A shRNA functional screen reveals Nme6 and Nme7 are crucial for embryonic stem cell renewal”, Stem Cells, 30(10), 2199-2211. Cite 7. (SCIE) (IF: 6.022; SCIE ranking: 23.1%,24.1%,13.2%,11.5%,16%)
  • Jan YH, Tsai HY, Yang CJ, Huang MS, Yang YF, Lai TC, Lee CH, Jeng YM, Huang CY, Su JL, Chuang YJ, Hsiao M*, 2012, “Adenylate Kinase-4 Is a Marker of Poor Clinical Outcomes That Promotes Metastasis of Lung Cancer by Downregulating the Transcription Factor ATF3.”, Cancer Res, 72(19), 5119-5129. Cite 14. (SCIE) (IF: 9.727; SCIE ranking: 7.8%)
  • Chang PH, Hwang-Verslues WW, Chang YC, Chen CC, Hsiao M, Jeng YM, Chang KJ, Lee EY, Shew JY, Lee WH, 2012, “Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/beta-catenin pathway.”, Cancer Res, 72(18), 4652-4661. Cite 32. (SCIE) (IF: 9.727; SCIE ranking: 7.8%)
  • Lin FC, Liu YP, Lai CH, Shan YS, Cheng HC, Hsu PI, Lee CH, Lee YC, Wang HY, Wang CH, Cheng JQ, Hsiao M*, Lu PJ, 2012, “RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells.”, Oncogene, 31(39), 4302-4316. Cite 42. (SCIE) (IF: 7.971; SCIE ranking: 15.9%,7.9%,9.8%,10.7%)
  • Lin FR, Huang SY, Hung KH, Su ST, Chung CH, Matsuzawa A, Hsiao M, Ichijo H, Lin KI, 2012, “ASK1 promotes apoptosis of normal and malignant plasma cells.”, Blood, 120(5), 1039-1047. Cite 5. (SCIE) (IF: 17.794; SCIE ranking: 1.3%)
  • Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, Hsu MT, Wu JC, Huang HD, Shiao MS, Hsiao M*, Tsou AP, 2012, “MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis.”, Journal of Clinical Investigation, 122(8), 2884-2897. Cite 483. (SCIE) (IF: 11.864; SCIE ranking: 2.2%)
  • Cheng WH, Lu PJ, Hsiao M, Hsiao CH, Ho WY, Cheng PW, Lin CT, Hong LZ, Tseng CJ, 2012, “Renin activates PI3K-Akt-eNOS signaling through the AT1 receptor and Mas receptor to modulate central blood pressure control in the nucleus tractus solitarii.”, Brit J Pharmacol, 166(7), 2024-2035. Cite 13. (SCIE) (IF: 7.73; SCIE ranking: 3.3%)
  • Wang HY, Juo LI, Lin YT, Hsiao M, Lin JT, Tsai CH, Tzeng YH, Chuang YC, Chang NS, Yang CN, Lu PJ, 2012, “WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3beta”, Cell Death Differ, 19(6), 1049-1059. Cite 15. (SCIE) (IF: 10.717; SCIE ranking: 8.7%,6.4%)
  • Shih MC, Chen JY, Wu YC, Jan YH, Yang BM, Lu PJ, Cheng HC, Huang MS, Yang CJ, Hsiao M, Lai JM, 2012, “TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.”, Oncogene, 31(19), 2389-2400. Cite 35. (SCIE) (IF: 7.971; SCIE ranking: 15.9%,7.9%,9.8%,10.7%)
  • Chuang CY, Lin KI, Hsiao M, Stone L, Chen HF, Huang YH, Lin SP, Ho HN, Kuo HC, 2012, “Meiotic competent human germ cell-like cells derived from human embryonic stem cells induced by BMP4/WNT3A signaling and OCT4/EpCAM selection.”, J Biol Chem, 287(18), 14389-14401. Cite 24. (SCIE) (IF: 4.238; SCIE ranking: 29.3%)
  • Chien MH, Bien MY, Ku CC, Chang YC, Pao HY, Yang YL, Hsiao M, Chen CL, Ho JH, 2012, “Systemic human orbital fat-derived stem/stromal cell transplantation ameliorates acute inflammation in lipopolysaccharide-induced acute lung injury.”, Crit Care Med, 40(4), 1245-1253 Cite 23. (SCIE) (IF: 7.414; SCIE ranking: 13.9%)
  • Sanjiv K, Su TL, Suman S, Kakadiya R, Lai TC, Wang HY, Hsiao M, Lee TC, 2012, “The novel DNA alkylating agent BO-1090 suppresses the growth of human oral cavity cancer in xenografted and orthotopic mouse models.”, Int J Cancer, 130(6), 1440-1450, Cite 10. (SCIE) (IF: 5.145; SCIE ranking: 24.2%)
  • Cheng LC, Huang JH, Chen HM, lai TC, Liu RS, Hsiao M*, Chen CH, Her LJ, Tsai DP, 2012, “Seedless, silver-induced synthesis of star-shaped gold/silver bimetallic nanoparticles as high efficiency photothermal therapy reagent”, Journal of Materials Chemistry, 22(5), 2244-2253. Cite 129.
  • Peng JM, Chen YH, Hung SW, Chiu CF, Ho MY, Lee YJ, Lai TC, Hsiao M, Liang CM, Liang SM, 2012, “Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting alpha5beta1 integrin to down-regulate Akt and MMP-2.”, Brit J Pharmacol, 165(2), 479-493. Cite 8. (SCIE) (IF: 7.73; SCIE ranking: 3.3%)

Lee, Wen-Hwa

  • Chang PH, Hwang-Verslues WW, Chang YC, Chen CC, Hsiao M, Jeng YM, Chang KJ, Lee EY, Shew JY*, Lee WH*, 2012, “Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/beta-catenin pathway.”, Cancer research, 72(18), 4652-4661. (SCIE) (IF: 9.727; SCIE ranking: 7.8%)
  • Tyan SW, Hsu CH, Peng KL, Chen CC, Kuo WH, Lee EY, Shew JY, Chang KJ, Juan LJ*, Lee WH*, 2012, “Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change.”, PLoS One, 7(4), e35128. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Wei PC, Hsieh YH, Su MI, Jiang X, Hsu PH, Lo WT, Weng JY, Jeng YM, Wang JM, Chen PL, Chang YC, Lee KF, Tsai MD, Shew JY*, Lee WH*, 2012, “Loss of the Oxidative Stress Sensor NPGPx Compromises GRP78 Chaperone Activity and Induces Systemic Disease.”, Molecular cell, 48(5), 747-759. (SCIE) (IF: 15.584; SCIE ranking: 1.3%,5.6%)
  • Chen PL, Chen CF, Chen Y, Guo XE, Huang CK, Shew JY, Reddick RL, Wallace DC, Lee WH, 2012, “Mitochondrial genome instability resulting from SUV3 haploinsufficiency leads to tumorigenesis and shortened lifespan.”, Oncogene, 32(9), 1193-1201. (SCIE) (IF: 7.971; SCIE ranking: 15.9%,7.9%,9.8%,10.7%)
  • Wei PC, Lo WT, Su MI, Shew JY, Lee WH*., 2012, “Non-targeting siRNA induces NPGPx expression to cooperate with exoribonuclease XRN2 for releasing the stress.”, Nucleic acids research, 40(1), 323-332. (SCIE) (IF: 11.502; SCIE ranking: 5.1%)

Lin, Kuo-I

  • Lin, F.-R., Huang, S.-Y., Hung, K.- H., Su, S.-T., Chung, C.-H., Matsuazwa, A., Hsiao, M., Ichijo, H. and Lin, K.-I*, 2012, “ASK1 promotes apoptosis of normal and malignant plasma cells”, Blood, 120(5), 1039-1047. (SCIE) (IF: 17.794; SCIE ranking: 1.3%)
  • Ying, H.-Y., Su, S.-T., Hsu, P.-H., Chang, C.-C., Lin, I-Y., Tseng, Y.-H., Tsai, M.-D., Shih, H.-M. and Lin, K.-I*, 2012, “SUMOylation of Blimp-1 is critical for plasma cell differentiation”, EMBO REPORTS, 13, 631-637. (SCIE) (IF: 7.497; SCIE ranking: 16.9%,10.8%)
  • Hsu Y, Lu XA, Zulueta MM, Tsai CM, Lin KI, Hung SC, Wong CH., 2012, “Acyl and Silyl Group Effects in Reactivity-Based One-Pot Glycosylation: Synthesis of Embryonic Stem Cell Surface Carbohydrates Lc(4) and IV(2)Fuc-Lc(4)”, J Am Chem Soc., 134(10), 4549-4552. (SCIE) (IF: 14.612; SCIE ranking: 7.3%)
  • Chuang, C.-Y., Lin, K.-I, Hsiao, M., Stone, L., Chen, H.-F., Huang, Y.-H., Lin, S.-P., Ho, H.-N.,and Kuo, H.-C., 2012, “Meiotic competent human germ cell-like cells derived from human embryonic stem cells induced by BMP4/WNT3A signaling and OCT4/EpCAM selection.”, JOURNAL OF BIOLOGICAL CHEMISTRY, 287, 14389-14401. (SCIE) (IF: 4.238; SCIE ranking: 29.3%)
  • Wu, Y.-H., Yang, C.-Y., Chien, W.-L., Lin, K.-I and Lai, M.-Z., 2012, “Removal of Syndecan-1 promotes TRAIL-induced apoptosis in myeloma cells.”, J. Immunol., 188, 2914-2921. (SCIE) (IF: 4.886; SCIE ranking: 28.3%)

Lu, Joyce Jean

  • Wang, C. H., Ma, N. H., Lin, Y.T., Wu, C.C., Hsiao M., Lu, F. L., Yu, C.C., Chen, S.Y., and Lu, J.*, 2012, “A shRNA functional screening in embryonic stem cells reveals Nme6 and Nme7 signaling are crucial for stem cell renewal”, Stem Cells, 30(10), 2199-2211. (SCIE) (IF: 6.022; SCIE ranking: 23.1%,24.1%,13.2%,11.5%,16%)
  • Chou YC, Chen CL, Yeh TH, Lin SJ, Chen MR, Doong SL, Lu J, Tsai CH, 2012, “Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis.”, The American Journal of Pathology, 181(5), 1773-1781. (SCIE) (IF: 3.491; SCIE ranking: 24.4%)
  • Chan CC, Cheng LY, Lu J, Huang YH, Chiou SH, Tsai PH, Huo TI, Lin HC, Lee FY, 2012, “The Role of Interferon-gamma Inducible Protein-10 in a Mouse Model of Acute Liver Injury Post Induced Pluripotent Stem Cells Transplantation.”, PLoS One, 7(12), e50577. (SCIE) (IF: 2.74; SCIE ranking: 38%)

Shen, Chia-Ning

  • Tsai ST, Tsou CC, Mao WY, Chang WC, Han HY, Hsu WL, Li CL, Shen CN*, Chen CH*, 2012, “Label-free quantitative proteomics of CD133-positive liver cancer stem cells.”, Proteome science, 10(1), 69. (SCIE) (IF: 2.811; SCIE ranking: 46.2%,84.8%)
  • Tsai HA, Shen CN, Chang YC, 2012, “The Use of Surface Properties to Control the Growth and Differentiation of Mouse Fetal Liver Stem/Progenitor Cell Colonies.”, Biomacromolecules, 13(11), 3483-3493. (SCIE) (IF: 6.092; SCIE ranking: 14.1%,5.3%,5.6%)
  • Wu YC, Ling TY, Lu SH, Kuo HC, Ho HN, Yeh SD, Shen CN*, Huang YH*, 2012, “Chemotherapeutic Sensitivity of Testicular Germ Cell Tumors Under Hypoxic Conditions Is Negatively Regulated by SENP1-Controlled Sumoylation of OCT4.”, Cancer Research, 72(19), 4963-4973. (SCIE) (IF: 9.727; SCIE ranking: 7.8%)
  • Chu CY, Chen CF, Rajendran RS, Shen CN, Chen TH, Yen CC, Chuang CK, Lin DS, Hsiao CD, 2012, “Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish.”, PloS One, 7(5), e36474. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Liao WY, Shen CN, Lin LH, Yang YL, Han HY, Chen JW, Kuo SC, Wu SH, Liaw CC, 2012, “Asperjinone, a Nor-Neolignan, and Terrein, a Suppressor of ABCG2-Expressing Breast Cancer Cells, from Thermophilic Aspergillus terreus.”, Journal of Natural Products, 75(4), 630-635. (SCIE) (IF: 3.782; SCIE ranking: 29.5%,25.1%,13.7%)

Yu, Alice Lin-Tsing

  • Lin HC, Lin JL, Lin HH, Tsai SW, Yu AL, Chen RL, Chen CH., 2012, “High Speed Mass Measurement of Nanoparticle and Virus.”, ANALYTICAL CHEMISTRY, 84(11), 4965-4969. (SCIE) (IF: 6.785; SCIE ranking: 8.1%)
  • Matthay KK, George RE, Yu AL., 2012, “Promising therapeutic targets in neuroblastoma.”, CLINICAL CANCER RESEARCH, 18(10), 2740-2753. (SCIE) (IF: 10.107; SCIE ranking: 7.4%)
  • Lin HH, Li YC, Chang CH, Liu C, Yu AL*, Chen CH*, 2012, “Single Nuclei Raman Spectroscopy for Drug Evaluation.”, ANALYTICAL CHEMISTRY, 84(1), 113-120. (SCIE) (IF: 6.785; SCIE ranking: 8.1%)
  • Guizzunti G, Theodorakis EA, Yu AL, Zurzolo C, Batova A, 2012, “Cluvenone induces apoptosis via a direct target in mitochondria: a possible mechanism to circumvent chemo-resistance?”, Investigational new drugs, 30(5), 1841-1848. (SCIE) (IF: 3.525; SCIE ranking: 44.7%,29.5%)
  • Tsai HJ, Chi LA, Yu AL, 2012, “Monoclonal antibodies targeting the synthetic peptide corresponding to the polybasic cleavage site on H5N1 influenza hemagglutinin.”, Journal of biomedical science, 19, 37. (SCIE) (IF: 5.762; SCIE ranking: 24.1%,12.2%)
  • Cho HC, Liao CH, Yu AL, Yu J, 2012, “Surface markers in stem cells and cancer from the perspective of glycomic analysis.”, The International journal of biological markers, 27(4), 344-352. (SCIE) (IF: 1.746; SCIE ranking: 77.6%,88.5%)
  • Hsieh MH, Hung JT, Liw YW, Lu YJ, Wong CH, Yu AL, Liang PH, 2012, “Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of alpha-GalCer for NKT cell activation.”, Chembiochem : a European journal of chemical biology, 13(11), 1689-1697. (SCIE) (IF: 2.576; SCIE ranking: 57.4%,63.3%)

Publications